Global Swine Vaccines Market Size, Manufacturers, Opportunities and Forecast to 2030
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
According to APO Research, The global Swine Vaccines market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Vaccines.
The Swine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
According to APO Research, The global Swine Vaccines market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Vaccines.
The Swine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- ChengDu Tecbond
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Others
- Government Tender
- Market Sales
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Swine Vaccines Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Swine Vaccines Sales Estimates and Forecasts (2019-2030)
1.3 Swine Vaccines Market by Type
1.3.1 CSF Vaccines
1.3.2 FMD Vaccines
1.3.3 Porcine Circovirus Vaccines
1.3.4 PRRS Vaccines
1.3.5 Others
1.4 Global Swine Vaccines Market Size by Type
1.4.1 Global Swine Vaccines Market Size Overview by Type (2019-2030)
1.4.2 Global Swine Vaccines Historic Market Size Review by Type (2019-2024)
1.4.3 Global Swine Vaccines Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Swine Vaccines Sales Breakdown by Type (2019-2024)
1.5.2 Europe Swine Vaccines Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Swine Vaccines Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Swine Vaccines Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Swine Vaccines Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Swine Vaccines Industry Trends
2.2 Swine Vaccines Industry Drivers
2.3 Swine Vaccines Industry Opportunities and Challenges
2.4 Swine Vaccines Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Swine Vaccines Revenue (2019-2024)
3.2 Global Top Players by Swine Vaccines Sales (2019-2024)
3.3 Global Top Players by Swine Vaccines Price (2019-2024)
3.4 Global Swine Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Swine Vaccines Key Company Manufacturing Sites & Headquarters
3.6 Global Swine Vaccines Company, Product Type & Application
3.7 Global Swine Vaccines Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Swine Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Swine Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Swine Vaccines Tier 1, Tier 2, and Tier
4 SWINE VACCINES REGIONAL STATUS AND OUTLOOK
4.1 Global Swine Vaccines Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Swine Vaccines Historic Market Size by Region
4.2.1 Global Swine Vaccines Sales in Volume by Region (2019-2024)
4.2.2 Global Swine Vaccines Sales in Value by Region (2019-2024)
4.2.3 Global Swine Vaccines Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Swine Vaccines Forecasted Market Size by Region
4.3.1 Global Swine Vaccines Sales in Volume by Region (2025-2030)
4.3.2 Global Swine Vaccines Sales in Value by Region (2025-2030)
4.3.3 Global Swine Vaccines Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 SWINE VACCINES BY APPLICATION
5.1 Swine Vaccines Market by Application
5.1.1 Government Tender
5.1.2 Market Sales
5.2 Global Swine Vaccines Market Size by Application
5.2.1 Global Swine Vaccines Market Size Overview by Application (2019-2030)
5.2.2 Global Swine Vaccines Historic Market Size Review by Application (2019-2024)
5.2.3 Global Swine Vaccines Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Swine Vaccines Sales Breakdown by Application (2019-2024)
5.3.2 Europe Swine Vaccines Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Swine Vaccines Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Swine Vaccines Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Swine Vaccines Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Merck
6.1.1 Merck Comapny Information
6.1.2 Merck Business Overview
6.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Swine Vaccines Product Portfolio
6.1.5 Merck Recent Developments
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Comapny Information
6.2.2 Boehringer Ingelheim Business Overview
6.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Comapny Information
6.3.2 Jinyu Bio-Technology Business Overview
6.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments
6.4 CAHIC
6.4.1 CAHIC Comapny Information
6.4.2 CAHIC Business Overview
6.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CAHIC Swine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments
6.5 Tecon
6.5.1 Tecon Comapny Information
6.5.2 Tecon Business Overview
6.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tecon Swine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments
6.6 Zoetis
6.6.1 Zoetis Comapny Information
6.6.2 Zoetis Business Overview
6.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zoetis Swine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments
6.7 Ceva
6.7.1 Ceva Comapny Information
6.7.2 Ceva Business Overview
6.7.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ceva Swine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments
6.8 Hile Bio
6.8.1 Hile Bio Comapny Information
6.8.2 Hile Bio Business Overview
6.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hile Bio Swine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments
6.9 Chopper Biology
6.9.1 Chopper Biology Comapny Information
6.9.2 Chopper Biology Business Overview
6.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chopper Biology Swine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments
6.10 WINSUN
6.10.1 WINSUN Comapny Information
6.10.2 WINSUN Business Overview
6.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WINSUN Swine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments
6.11 Hipra
6.11.1 Hipra Comapny Information
6.11.2 Hipra Business Overview
6.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hipra Swine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments
6.12 Ringpu Biology
6.12.1 Ringpu Biology Comapny Information
6.12.2 Ringpu Biology Business Overview
6.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ringpu Biology Swine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments
6.13 ChengDu Tecbond
6.13.1 ChengDu Tecbond Comapny Information
6.13.2 ChengDu Tecbond Business Overview
6.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
6.13.5 ChengDu Tecbond Recent Developments
6.14 DHN
6.14.1 DHN Comapny Information
6.14.2 DHN Business Overview
6.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 DHN Swine Vaccines Product Portfolio
6.14.5 DHN Recent Developments
6.15 CAVAC
6.15.1 CAVAC Comapny Information
6.15.2 CAVAC Business Overview
6.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CAVAC Swine Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments
6.16 Virbac
6.16.1 Virbac Comapny Information
6.16.2 Virbac Business Overview
6.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Virbac Swine Vaccines Product Portfolio
6.16.5 Virbac Recent Developments
6.17 HVRI
6.17.1 HVRI Comapny Information
6.17.2 HVRI Business Overview
6.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 HVRI Swine Vaccines Product Portfolio
6.17.5 HVRI Recent Developments
6.18 Bioveta
6.18.1 Bioveta Comapny Information
6.18.2 Bioveta Business Overview
6.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bioveta Swine Vaccines Product Portfolio
6.18.5 Bioveta Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Swine Vaccines Sales by Country
7.1.1 North America Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Swine Vaccines Sales by Country (2019-2024)
7.1.3 North America Swine Vaccines Sales Forecast by Country (2025-2030)
7.2 North America Swine Vaccines Market Size by Country
7.2.1 North America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Swine Vaccines Market Size by Country (2019-2024)
7.2.3 North America Swine Vaccines Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Swine Vaccines Sales by Country
8.1.1 Europe Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Swine Vaccines Sales by Country (2019-2024)
8.1.3 Europe Swine Vaccines Sales Forecast by Country (2025-2030)
8.2 Europe Swine Vaccines Market Size by Country
8.2.1 Europe Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Swine Vaccines Market Size by Country (2019-2024)
8.2.3 Europe Swine Vaccines Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Swine Vaccines Sales by Country
9.1.1 Asia-Pacific Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Swine Vaccines Sales by Country (2019-2024)
9.1.3 Asia-Pacific Swine Vaccines Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Swine Vaccines Market Size by Country
9.2.1 Asia-Pacific Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Swine Vaccines Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Swine Vaccines Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Swine Vaccines Sales by Country
10.1.1 Latin America Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Swine Vaccines Sales by Country (2019-2024)
10.1.3 Latin America Swine Vaccines Sales Forecast by Country (2025-2030)
10.2 Latin America Swine Vaccines Market Size by Country
10.2.1 Latin America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Swine Vaccines Market Size by Country (2019-2024)
10.2.3 Latin America Swine Vaccines Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Swine Vaccines Sales by Country
11.1.1 Middle East and Africa Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Swine Vaccines Sales by Country (2019-2024)
11.1.3 Middle East and Africa Swine Vaccines Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Swine Vaccines Market Size by Country
11.2.1 Middle East and Africa Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Swine Vaccines Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Swine Vaccines Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Swine Vaccines Value Chain Analysis
12.1.1 Swine Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Swine Vaccines Production Mode & Process
12.2 Swine Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Swine Vaccines Distributors
12.2.3 Swine Vaccines Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Swine Vaccines Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Swine Vaccines Sales Estimates and Forecasts (2019-2030)
1.3 Swine Vaccines Market by Type
1.3.1 CSF Vaccines
1.3.2 FMD Vaccines
1.3.3 Porcine Circovirus Vaccines
1.3.4 PRRS Vaccines
1.3.5 Others
1.4 Global Swine Vaccines Market Size by Type
1.4.1 Global Swine Vaccines Market Size Overview by Type (2019-2030)
1.4.2 Global Swine Vaccines Historic Market Size Review by Type (2019-2024)
1.4.3 Global Swine Vaccines Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Swine Vaccines Sales Breakdown by Type (2019-2024)
1.5.2 Europe Swine Vaccines Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Swine Vaccines Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Swine Vaccines Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Swine Vaccines Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Swine Vaccines Industry Trends
2.2 Swine Vaccines Industry Drivers
2.3 Swine Vaccines Industry Opportunities and Challenges
2.4 Swine Vaccines Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Swine Vaccines Revenue (2019-2024)
3.2 Global Top Players by Swine Vaccines Sales (2019-2024)
3.3 Global Top Players by Swine Vaccines Price (2019-2024)
3.4 Global Swine Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Swine Vaccines Key Company Manufacturing Sites & Headquarters
3.6 Global Swine Vaccines Company, Product Type & Application
3.7 Global Swine Vaccines Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Swine Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Swine Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Swine Vaccines Tier 1, Tier 2, and Tier
4 SWINE VACCINES REGIONAL STATUS AND OUTLOOK
4.1 Global Swine Vaccines Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Swine Vaccines Historic Market Size by Region
4.2.1 Global Swine Vaccines Sales in Volume by Region (2019-2024)
4.2.2 Global Swine Vaccines Sales in Value by Region (2019-2024)
4.2.3 Global Swine Vaccines Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Swine Vaccines Forecasted Market Size by Region
4.3.1 Global Swine Vaccines Sales in Volume by Region (2025-2030)
4.3.2 Global Swine Vaccines Sales in Value by Region (2025-2030)
4.3.3 Global Swine Vaccines Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 SWINE VACCINES BY APPLICATION
5.1 Swine Vaccines Market by Application
5.1.1 Government Tender
5.1.2 Market Sales
5.2 Global Swine Vaccines Market Size by Application
5.2.1 Global Swine Vaccines Market Size Overview by Application (2019-2030)
5.2.2 Global Swine Vaccines Historic Market Size Review by Application (2019-2024)
5.2.3 Global Swine Vaccines Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Swine Vaccines Sales Breakdown by Application (2019-2024)
5.3.2 Europe Swine Vaccines Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Swine Vaccines Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Swine Vaccines Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Swine Vaccines Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Merck
6.1.1 Merck Comapny Information
6.1.2 Merck Business Overview
6.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Swine Vaccines Product Portfolio
6.1.5 Merck Recent Developments
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Comapny Information
6.2.2 Boehringer Ingelheim Business Overview
6.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Comapny Information
6.3.2 Jinyu Bio-Technology Business Overview
6.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments
6.4 CAHIC
6.4.1 CAHIC Comapny Information
6.4.2 CAHIC Business Overview
6.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CAHIC Swine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments
6.5 Tecon
6.5.1 Tecon Comapny Information
6.5.2 Tecon Business Overview
6.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tecon Swine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments
6.6 Zoetis
6.6.1 Zoetis Comapny Information
6.6.2 Zoetis Business Overview
6.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zoetis Swine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments
6.7 Ceva
6.7.1 Ceva Comapny Information
6.7.2 Ceva Business Overview
6.7.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ceva Swine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments
6.8 Hile Bio
6.8.1 Hile Bio Comapny Information
6.8.2 Hile Bio Business Overview
6.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hile Bio Swine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments
6.9 Chopper Biology
6.9.1 Chopper Biology Comapny Information
6.9.2 Chopper Biology Business Overview
6.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chopper Biology Swine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments
6.10 WINSUN
6.10.1 WINSUN Comapny Information
6.10.2 WINSUN Business Overview
6.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WINSUN Swine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments
6.11 Hipra
6.11.1 Hipra Comapny Information
6.11.2 Hipra Business Overview
6.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hipra Swine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments
6.12 Ringpu Biology
6.12.1 Ringpu Biology Comapny Information
6.12.2 Ringpu Biology Business Overview
6.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ringpu Biology Swine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments
6.13 ChengDu Tecbond
6.13.1 ChengDu Tecbond Comapny Information
6.13.2 ChengDu Tecbond Business Overview
6.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
6.13.5 ChengDu Tecbond Recent Developments
6.14 DHN
6.14.1 DHN Comapny Information
6.14.2 DHN Business Overview
6.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 DHN Swine Vaccines Product Portfolio
6.14.5 DHN Recent Developments
6.15 CAVAC
6.15.1 CAVAC Comapny Information
6.15.2 CAVAC Business Overview
6.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CAVAC Swine Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments
6.16 Virbac
6.16.1 Virbac Comapny Information
6.16.2 Virbac Business Overview
6.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Virbac Swine Vaccines Product Portfolio
6.16.5 Virbac Recent Developments
6.17 HVRI
6.17.1 HVRI Comapny Information
6.17.2 HVRI Business Overview
6.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 HVRI Swine Vaccines Product Portfolio
6.17.5 HVRI Recent Developments
6.18 Bioveta
6.18.1 Bioveta Comapny Information
6.18.2 Bioveta Business Overview
6.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bioveta Swine Vaccines Product Portfolio
6.18.5 Bioveta Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Swine Vaccines Sales by Country
7.1.1 North America Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Swine Vaccines Sales by Country (2019-2024)
7.1.3 North America Swine Vaccines Sales Forecast by Country (2025-2030)
7.2 North America Swine Vaccines Market Size by Country
7.2.1 North America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Swine Vaccines Market Size by Country (2019-2024)
7.2.3 North America Swine Vaccines Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Swine Vaccines Sales by Country
8.1.1 Europe Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Swine Vaccines Sales by Country (2019-2024)
8.1.3 Europe Swine Vaccines Sales Forecast by Country (2025-2030)
8.2 Europe Swine Vaccines Market Size by Country
8.2.1 Europe Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Swine Vaccines Market Size by Country (2019-2024)
8.2.3 Europe Swine Vaccines Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Swine Vaccines Sales by Country
9.1.1 Asia-Pacific Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Swine Vaccines Sales by Country (2019-2024)
9.1.3 Asia-Pacific Swine Vaccines Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Swine Vaccines Market Size by Country
9.2.1 Asia-Pacific Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Swine Vaccines Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Swine Vaccines Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Swine Vaccines Sales by Country
10.1.1 Latin America Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Swine Vaccines Sales by Country (2019-2024)
10.1.3 Latin America Swine Vaccines Sales Forecast by Country (2025-2030)
10.2 Latin America Swine Vaccines Market Size by Country
10.2.1 Latin America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Swine Vaccines Market Size by Country (2019-2024)
10.2.3 Latin America Swine Vaccines Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Swine Vaccines Sales by Country
11.1.1 Middle East and Africa Swine Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Swine Vaccines Sales by Country (2019-2024)
11.1.3 Middle East and Africa Swine Vaccines Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Swine Vaccines Market Size by Country
11.2.1 Middle East and Africa Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Swine Vaccines Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Swine Vaccines Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Swine Vaccines Value Chain Analysis
12.1.1 Swine Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Swine Vaccines Production Mode & Process
12.2 Swine Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Swine Vaccines Distributors
12.2.3 Swine Vaccines Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
